Literature DB >> 22087525

Recurrent pulmonary tumoral embolism and sudden death as the presenting symptom of Wilms' tumor.

Afshin Mohammadi1.   

Abstract

Only 4-6% of children with renal tumor show inferior vena caval or right atrial infiltration at presentation. Tumor emboli are even rarer, and so far, sudden death as the presenting symptom has only been described at presentation in Wilms' tumor in eight cases. We report a unique case of Wilms' tumor that presented with small pulmonary emboli and immediately after as that was diagnosed before death by detection of small emboli and immediately after sudden death as massive pulmonary embolism. It seems that in cases of invasive vascular infiltration with a stable hemodynamic condition at diagnosis immediate surgery may be necessary.

Entities:  

Mesh:

Year:  2011        PMID: 22087525     DOI: 10.5578/tt.2405

Source DB:  PubMed          Journal:  Tuberk Toraks        ISSN: 0494-1373


  4 in total

1.  Pediatric Massive and Submassive Pulmonary Embolism: A Single-Center Experience.

Authors:  Catherine E Ross; Jenny A Shih; Monica E Kleinman; Michael W Donnino
Journal:  Hosp Pediatr       Date:  2020-02-11

2.  Investigating the dysfunctional pathogenesis of Wilms' tumor through a multidimensional integration strategy.

Authors:  Wenbiao Chen; Jia Zhuang; Lan Gong; Yong Dai; Hongyan Diao
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  Acute Management of High-Risk and Intermediate-Risk Pulmonary Embolism in Children: A Review.

Authors:  Catherine Ross; Riten Kumar; Marie-Claude Pelland-Marcotte; Shivani Mehta; Monica E Kleinman; Ravi R Thiagarajan; Muhammad B Ghbeis; Christina J VanderPluym; Kevin G Friedman; Diego Porras; Francis Fynn-Thompson; Samuel Z Goldhaber; Leonardo R Brandão
Journal:  Chest       Date:  2021-09-26       Impact factor: 9.410

Review 4.  Lessons from a patient with cardiac arrest due to massive pulmonary embolism as the initial presentation of Wilms tumor: a case report and literature review.

Authors:  Atsuna Fukuda; Takeshi Isoda; Naoya Sakamoto; Keisuke Nakajima; Tetsuya Ohta
Journal:  BMC Pediatr       Date:  2019-01-31       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.